120 related articles for article (PubMed ID: 24501285)
21. Patient-derived xenograft models-the future of personalised cancer treatment.
Bhimani J; Ball K; Stebbing J
Br J Cancer; 2020 Mar; 122(5):601-602. PubMed ID: 31919403
[TBL] [Abstract][Full Text] [Related]
22. Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice.
Martínez-Sabadell A; Ovejero Romero P; Arribas J; Arenas EJ
STAR Protoc; 2022 Dec; 3(4):101712. PubMed ID: 36317178
[TBL] [Abstract][Full Text] [Related]
23. [Textual research on the editions of Ben cao fa ming (Invention of Materia Medica)].
Li YQ
Zhonghua Yi Shi Za Zhi; 2013 Mar; 43(2):112-3. PubMed ID: 24135479
[TBL] [Abstract][Full Text] [Related]
24. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
25. Cancer: off by a whisker.
Dennis C
Nature; 2006 Aug; 442(7104):739-41. PubMed ID: 16915261
[No Abstract] [Full Text] [Related]
26. Gene-edited babies: Chinese Academy of Medical Sciences' response and action.
Wang C; Zhai X; Zhang X; Li L; Wang J; Liu DP;
Lancet; 2019 Jan; 393(10166):25-26. PubMed ID: 30522918
[No Abstract] [Full Text] [Related]
27. The types of Anthomyiidae (Diptera) in the Shanghai Entomological Museum, Chinese Academy of Science, China.
Zhang X; Zhu W
Zootaxa; 2014 Jan; 3756():1, 3-67. PubMed ID: 24869962
[TBL] [Abstract][Full Text] [Related]
28. Academia-industry alliance: Belfer Institute and sanofi-aventis collaborate to develop new cancer therapeutics.
Dis Model Mech; 2010; 3(11-12):669. PubMed ID: 21030419
[No Abstract] [Full Text] [Related]
29. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
30. As a guest of the Chinese Academy in Peking and Shanghai.
Gerwin R
Naturwissenschaften; 1975 Jun; 62(6):290-5. PubMed ID: 1196391
[TBL] [Abstract][Full Text] [Related]
31. Report on a visit to the institute of Materia Medica of the People's Republic of China.
Katz AM
J Mol Cell Cardiol; 1974 Aug; 6(4):291-5. PubMed ID: 4854118
[No Abstract] [Full Text] [Related]
32. [Project design and implementation of the fourth national survey Chinese matiera medica resources].
Huang LQ; Lu JW; Guo LP; Zhang XB; Zhao RH; Zhang BG; Li Y; Su GQ; Li DN
Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(5):625-8. PubMed ID: 23724663
[TBL] [Abstract][Full Text] [Related]
33. Patient-derived tumor xenograft models in drug development.
Hidalgo M
Clin Adv Hematol Oncol; 2017 Nov; 15(11):844-846. PubMed ID: 29200416
[No Abstract] [Full Text] [Related]
34. [Clinical cancer morphology (the current status of the problem and the paths for its further development). Formal speech presented 15 April 1985 at the All-Union Cancer Research Center of the Academy of Medical Sciences of the USSR].
Kraevskiĭ NA
Arkh Patol; 1985; 47(9):7-14. PubMed ID: 3907601
[No Abstract] [Full Text] [Related]
35. Antitumor effect of kigamicin D on mouse tumor models.
Masuda T; Ohba S; Kawada M; Osono M; Ikeda D; Esumi H; Kunimoto S
J Antibiot (Tokyo); 2006 Apr; 59(4):209-14. PubMed ID: 16830887
[TBL] [Abstract][Full Text] [Related]
36. The National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention: a new administrative structure for schistosomiasis control.
Zhou XN; Chen JX; Chen MG; Bergquist R
Acta Trop; 2005; 96(2-3):296-302. PubMed ID: 16126154
[TBL] [Abstract][Full Text] [Related]
37. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors.
Zhang L; Marrano P; Kumar S; Leadley M; Elias E; Thorner P; Baruchel S
Clin Cancer Res; 2013 Nov; 19(21):5972-83. PubMed ID: 23989978
[TBL] [Abstract][Full Text] [Related]
38. Catch of the day: zebrafish as a human cancer model.
Stoletov K; Klemke R
Oncogene; 2008 Jul; 27(33):4509-20. PubMed ID: 18372910
[TBL] [Abstract][Full Text] [Related]
39. Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer.
Hofner T; Macher-Goeppinger S; Klein C; Rigo-Watermeier T; Eisen C; Pahernik S; Hohenfellner M; Trumpp A; Sprick MR
J Urol; 2013 Dec; 190(6):2263-70. PubMed ID: 23820058
[TBL] [Abstract][Full Text] [Related]
40. Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint.
Wang ZY; Wang DM; Loo TY; Cheng Y; Chen LL; Shen JG; Yang DP; Chow LW; Guan XY; Chen JP
J Ethnopharmacol; 2011 Jan; 133(2):751-8. PubMed ID: 21073941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
